The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy.
Melvin
D C
DC
Lee
J K
JK
Belsey
E
E
Arnold
J
J
Murphy
R L
RL
D000410:Alanine Transaminase / Q000097:blood; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D016022:Case-Control Studies; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology
D019380:Anti-HIV Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase